dBio Appoints Bert Hoyt as Board Advisor to Advance Sports and Health Technology
LUXEMBOURG, April 24, 2025 – Decentralized Biotechnology Intelligence Holding Group Inc. (dBio), a pioneer in sports and health tech, has appointed Hubertus “Bert” Hoyt as its newest Board Advisor. Hoyt, former Vice President and General Manager at Nike, brings 32 years of experience in the sports industry to dBio’s mission of revolutionizing personalized healthcare and fitness technologies globally.
About dBio and Its Innovative Technologies
dBio is dedicated to empowering individuals to optimize their training, accelerate recovery, and reduce injury risk through personalized, data-driven feedback. The company’s proprietary technologies include:
- gMOTCloud: An AI-powered kinesiology wearable that captures detailed motion and gait metrics.
- StethoCloud: A lightweight wearable stethoscope enabling continuous heart and respiratory monitoring with AI-enhanced noise reduction.
These devices offer cloud-based analytics and virtual coaching support for healthier, safer, and more effective performance in exercise. With over 75 registered patents and a fully self-developed ecosystem, dBio provides a comprehensive solution for performance optimization and health management.
Bert Hoyt’s Background and Contributions
Hoyt began his career at Puma in 1989 and later joined Nike in 1998, where he served as Vice President & General Manager of Nike Western Europe and EMEA for nine years. He was instrumental in Nike’s growth in Europe, increasing revenue from US$3 billion to US$7 billion in Western Europe and over US$10 billion in EMEA, with a 24% EBIT. Since retiring from Nike in 2021, Hoyt has served as a non-executive Director at several companies, including JD Sports PLC and Cosnova GmbH.
“I’ve been involved in helping athletes improve their performance and overall well-being throughout my career. I’m joining dBio because I believe their innovations will be the next chapter in athlete performance and provide sports enthusiasts with precise data to improve their well-being,” Hoyt said.
With Hoyt on board, dBio continues to expand its global footprint, aiming to redefine the future of personalized health and performance technology through its cutting-edge wearable AIoT solutions and strategic partnerships across medical, academic, and athletic sectors.
